References in periodicals archive ?
Carnitor(R) SF and Carnitor(R) Oral Solution are indicated to treat primary systemic carnitine deficiency and for acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency.
Control lymphoblasts and fibroblasts were available from pediatric patients without a diagnosis of inborn error of metabolism and from controls, and had originally been obtained for carrier screening.
Aspartylglucosaminidase deficiency or aspartylglucosaminuria is an inborn error of metabolism caused by the deficiency of the lysosomal enzyme N-aspartyl-[beta]-glucosylaminidase (EC 3.
Carnitor Injection was approved in 1992 for the acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency.